GeorgeVan BurenIIMD

PubMed

• 28 citations
  Value of lymph node positivity in treatment planning for early stage pancreatic cancer
  Hop S. Tran Cao, Qianzi Zhang, Yvonne H. Sada, Eric J. Silberfein, Cary Hsu
  Surgery. 2017-09-01
• 90 citations
  A Prospective Randomized Multicenter Trial of Distal Pancreatectomy With and Without Routine Intraperitoneal Drainage.
  George Van Buren, Mark Bloomston, Carl Schmidt, Stephen W. Behrman, Nicholas J. Zyromski
  Annals of Surgery. 2017-09-01
• 31 citations
  Novel Methylated DNA Markers Discriminate Advanced Neoplasia in Pancreatic Cysts: Marker Discovery, Tissue Validation, and Cyst Fluid Testing.
  Shounak Majumder, William R. Taylor, Tracy C. Yab, Calise K. Berger, Brian A. Dukek
  The American Journal of Gastroenterology. 2019-09-01

Journal Articles

• Pancreaticoduodenectomy Without Drains: Interpretation of the Evidence  
  Van Buren G 2nd, Fisher WE, Ann Surg, 1/1/2015
• Treatment of bacteriobilia decreases wound infection rates after pancreaticoduodenectomy  
  Mohammed S, Evans C, Hodges SE, Silberfein E, Artinyan A, Mo Q, Issazadeh M, McElhany AL, Fisher WE, HPB (Oxford), 1/29/2013
• An assessment of the necessity of transfusion during pancreatoduodenectomy  
  Ross A, Mohammed S, Silberfein EJ, Artinyan A, Hodges SE, Fisher WE, Surgery, 1/1/2013
• Hepatocellular carcinoma survival in un- and underinsured patients  
  Harvin JA, Tsao K, Cen P, Ko TC, Wray CJ, J Surg Res, 1/1/2011
• Targeting the urokinase plasminogen activator receptor with a monoclonal antibody impairs the growth of human colorectal cancer in the liver  
  Gray MJ, Dallas NA, Xia L, Lim SJ, Fan F, Mazar A, Ellis LM, Cancer, 1/1/2009
• Chemoresistant Colorectal Cancer Cells, the Cancer Stem Cell Phenotype, and Increased Sensitivity to Insulin-like Growth Factor-I Receptor Inhibition  
  Dallas NA, Xia L, Fan F, Gray MJ, Gaur P, Samuel S, Kim MP, Lim SJ, Ellis LM, Cancer Res, 1/1/2009
• Neuropilin-2-mediated tumor growth and angiogenesis in pancreatic adenocarcinoma  
  Dallas NA, Gray MJ, Xia L, Fan F, Gaur P, Samuel S, Lim SJ, Arumugam T, Ramachandran V, Wang H, Ellis LM, Clin Cancer Res, 1/1/2008
• Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver  
  Gray MJ, Dallas NA, Xia L, Yang AD, Somcio RJ, Gaur P, Mangala LS, Vivas-Mejia PE, Fan F, Sanguino AM, Gallick GE, Lopez-Berestein G, Sood AK, Ellis LM, Oncogene, 1/1/2008
• Effect of chemotherapeutic stress on induction of vascular endothelial growth factor family members and receptors in human colorectal cancer cells  
  Fan F, Gray MJ, Dallas NA, Yang AD, Camp ER, Ellis LM, Mol Cancer Ther, 1/1/2008
• Effect of molecular therapeutics on liver regeneration in a murine model  
  Yang AD, Dallas NA, Gray MJ, Lim SJ, Xia L, Fan F, Somcio R, Wu Y, Hicklin DJ, Ellis LM, J Clin Oncol, 1/1/2008
• Therapeutic Targeting of Neuropilin-2 on Colorectal Carcinoma Cells Implanted in the Murine Liver  
  Gray MJ, Dallas NA, Xia L, Wang X, Yang AD, Somcio RJ, Lin YG, Lim S, Fan F, Mangala LS, Arumugam T, Logsdon CD, Lopez-Berestein G, Sood AK, Ellis LM, J Natl Cancer Inst, 1/1/2008
• Sequential stenotic strictures of the small bowel leading to obstruction  
  Teichgraeber DC, Ghorbani RP, Souchon EA, World J Gastroenterol, 1/1/2007
• Functional significance of vascular endothelial growth factor receptors on gastrointestinal cancer cells  
  Dallas NA, Fan F, Gray MJ, Lim SJ, Xia L, Ellis LM, Cancer Metastasis Rev, 1/1/2007
• The development and characterization of a human midgut carcinoid cell line  
  Rashid A, Yang AD, Abdalla EK, Gray MJ, Liu W, Somcio R, Fan F, Camp ER, Yao JC, Ellis LM, Clin Cancer Res, 1/1/2007
• Chronic Oxaliplatin Resistance Induces Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cell Lines  
  Yang AD, Fan F, Camp ER, Liu W, Somcio R, Gray MJ, Cheng H, Hoff PM, Ellis LM, Clinical Cancer Research, 1/1/2006
• The role of nitric oxide in mediating tumour blood flow  
  Camp ER, Yang AD, Gray MJ, Fan F, Somcio R, Ellis LM, Expert Opinion on Therapeutic Targets, 1/1/2006
• Join now to see all

Books/Book Chapters

• Operative Techniques in Surgery 
  Chapter: Chapter 33: Pancreaticoduodenectomy: Resection 
  Van Buren G 2nd, Fisher WELippincott, Williams, and Wilkins, Philadelphia, PAEdition 1st,2014
• Antiangiogenic Agents in Cancer Therapy 
  Chapter: Chapter 18: Challenges in translating anti-angiogenic therapy from the bench to bedside 
  Ellis LM, Dallas NA, Lim S, Xia L, Fan F, Gray MJHumana Press, Totowa, NJEdition 2nd,2007

Abstracts/Posters

• The Impact of Level One Data on Pancreatic Surgical Practice
  Mederos MA, McElhany A, Mohammed S, Fisher WE, Debakey Department of Surgery Research Day, Houston, TX, 1/3/2015
• The Impact Of Inappropriate Blood Transfusion During Pancreaticoduodenectomy
  Mohammed S, Ross A, Silberfein EJ, Artinyan A, Hodges SE, Fisher WE, ASC 2013, New Orleans, 1/1/2013
• Phase II trial of fixed-dose rate gemcitabine, bevacizumab, and concurrent 30 Gy radiotherapy as preoperative treatment for potentially resectable pancreatic adenocarc...
  Ramanathan R, Krasinskas A, Smith R, Abood G, Shaui Y, Potter D, Bahary N, Lembersky B, Zureikat AH, Bartlett DL, Zeh HJ, Moser AJ, ASCO 2012 Gastrointestinal Cancers Symposium, 1/1/2012
• Margin Distance Is Not an Independent Predictor of Survival After R0 Resection for Pancreatic Adenocarcinoma
  Zeh HJ, Krasinskas A, Gooding W, Steve J, Lee KK, Magge D, Daouadi M , Bartlett DL, Moser AJ, Zureikat AH, ASCO 2012 Gastrointestinal Cancers Symposium, 1/1/2012
• Hepatocellular carcinoma survival in un- and underinsured patients
  Harvin JA, Tsao K, Cen P, Ko TC, Wray CJ, Academic Surgical Congress, San Antonio, TX, 1/1/2010
• Blockade of In Vivo Tumor Growth of Newly Established Human Midgut Carcinoid Tumors by Src Inhibition
  Gaur P, Samuel S, Bose D, Dallas NA, Gray MJ, Xia L, Fan F, Rashid A, Yao JC, Ellis LM, ASCO, 2009 Gastrointestinal Cancers Symp, San Francisco, CA, 1/1/2009
• A monoclonal antibody targeting the human urokinase plasminogen activator receptor (uPAR) inhibits the growth of established colon cancer liver tumors
  Gray MJ, Juarez J, Donate F, Mazar AP, Ellis LM, ASCO, 2008 Gastrointestinal Cancers Symp, Orlando, FL, 1/1/2008
• Characterization of molecular targets in newly established human neuroendocrine tumor (NET) cell lines
  Gaur P, Dallas NA, Samuel S, Xia L, Fan F, Gray MJ, Lim SJ, Woodall ML, Yao JC, Ellis LM, ASCO, 2008 Gastrointestinal Cancers Symp, Orlando, FL, 1/1/2008
• Neuropilin-2 expression decreases tumor cell survival signaling, migration, invasion and tumor growth in pancreatic adenocarcinoma
  Dallas NA, Gray MJ, Xia L, Fan F, Gaur P, Lim SJ, Ellis LM, ASCO, 2008 Gastrointestinal Cancers Symp, Orlando, FL, 1/1/2008
• Anti-Epidermal Growth Factor Receptor Therapy Does Not Impair Liver Regeneration in a Murine Model
  Dallas NA, Yang AD, Gray MJ, Lim SJ, Xia L, Fan F, Wu Y, Hicklin DJ, Ellis LM, AACR Annual Meeting, Los Angeles, CA, 1/1/2007
• Id2 Regulates Survival, Proliferation, and Chemoresistance in Colorectal Carinomas
  Gray MJ, Dallas NA, Lim SJ, Fan F, Xia L, Ellis LM, 7th AACR-JCA Joint Internl Conf., Waikoloa, HI, 1/1/2007
• A human mid-gut carcinoid model
  Rashid A, Yang AD, Abdalla EK, Gray MJ, Liu W, Fan F, Camp ER, Yao JC, Ellis LM, ASCO, 2007 Gastrointestinal Cancers Symposium, Orlando, FL, 1/1/2007
• Neuropilin-2 mediates survival signaling, cellular proliferation and chemosensitivity in pancreatic adenocarcinoma cell lines
  Dallas NA, Gray MJ, Fan F, Xia L, Lim SJ, Ellis LM, 9th Interl Symp on Anti-Angiogenic Agents, San Diego, CA, 1/1/2007
• Neuropilin-2 Regulates Growth, Survival, and Angiogenesis in Colorectal Cancer
  Gray MJ, Xia L, Dallas NA, Lim SJ, Fan F, Ellis LM, 9th Interl Symp on Anti-Angiogenic Agents, San Diego, CA, 1/1/2007
• The Development and Characterization of a Human Mid-gut Carcinoid Cell Line
  Rashid A, Yang AD, Abdalla EK, Gray MJ, Liu W, Fan F, Camp ER, Yao JC, Ellis LM, The Society for Surgical Oncology 60th Annual Cancer Symposium, Washington, DC, 1/1/2007
• Effect of Chemotherapeutic Stress on Induction of VEGF Family Members in Human Colorectal Cancer Cells
  Fan F, Gray MJ, Yang AD, Camp ER, Liu W, Somcio RJ, Ellis LM, AACR Annual Meeting, Los Angeles, CA, 1/1/2007
• Neuropilin-2 Mediates Survival, Migration, and Invasion in Gastrointestinal Tumor Cells
  Dallas NA, Gray MJ, Xia L, Lim SJ, Ellis LM, AACR Annual Meeting, Los Angeles, CA, 1/1/2007
• A monoclonal antibody targeting the human urokinase plasminogen activator receptor (uPAR) combined with bevacizumab inhibits the growth of colon cancer metastases in t...
  Gray M, Dallas NA, Xia L, Juarez J, Parry GC, Doñate F, Mazar AP, and Ellis LM, AACR - NCI – EORTC Internl Conf on "Molecular Targets and Cancer Therapeutics", San Francisco, CA, 1/1/2007
• Ectopic Phyllodes Tumor In the Vulva: Case report and review of the literature
  Friel M, Veras E, Robinson E, Southwestern Surgical Congress 59th Annual Meeting, Honolulu, HI, 1/1/2006
• Anti-Vascular Endothelial Growth Factor Receptor Therapy Does Not Impair Liver Regeneration After Partial Hepatectomy in Mice
  Yang AD, Somcio RJ, Fan F, Camp ER, Gray MJ, Cheng HY, Wu Y, Hicklin DJ, Ellis LM, 8th Internl Symp on Anti-Angiogenic Agents, San Diego, CA, 1/1/2006
• The effect of gut ischemia/reperfusion on ileal muscle contractility
  Hassoun H, Moore FA, Lai M, Weisbrodt N, Annual Meeting of The Federation of American Societies of Experimental Biology, Orlando FL, 1/31/2001
• Join now to see all

Lectures

• Faculty Education and Development: Maintenance of Certification 
  Baylor College of Medicine - 1/9/2015
• A Randomized Prospective Multicenter Trial of Pancreaticoduodenectomy With and Without Routine Intraperitoneal Drainage 
  1/1/2014
• Colon Adenocarcinoma Lymph Node Analysis 
  1/1/2014
• Translational Opportunities in Pancreatic Adenocarcinoma 
  Baylor College of Medicine, Graduate School, Houston, TX - 1/1/2014
• Advances in Pancreatic Surgery: Are we improving? 
  University of Texas Health Science Center, Houston, TX - 1/1/2014
• Surgical Treatment of Pancreatic Neuroendocrine Tumors 
  Houston TX - 1/1/2014
• Advances in Pancreatic Adenocarcinoma 
  Baylor College of Medicine, Houston, TX - 1/1/2013
• Neoadjuvant Therapy for Gastrointestinal Malignancies 
  Arthur Temple, Sr. Regional Cancer Center, Lufkin, TX - 1/1/2013
• Phase II trial of fixed-dose rate gemcitabine, bevacizumab, and concurrent 30 Gy radiotherapy as preoperative treatment for potentially resectable pancreatic adenocarc... 
  San Diego - 1/1/2012
• Margin Distance Is Not an Independent Predictor of Survival After R0 Resection for Pancreatic Adenocarcinoma 
  San Diego - 1/1/2012
• Neoadjuvant Therapy for Pancreatic Cancer 
  University of Texas Health Science Center, Houston, TX - 1/1/2012
• Locally Advance Pancreatic Adenocarcinoma 
  UPMC Shadyside Tumor Board, Pittsburgh, PA - 1/1/2010
• The effect of molecular therapeutics on liver regeneration in a murine model 
  New Orleans, LA - 1/1/2007
• Surgical Resection of Benign Hepatic Tumors: Yes or No 
  University of Texas Health Science Center, Houston, TX - 1/1/2007
• Anti-VEGFR and Anti-EGFR Therapy in Liver Regeneration 
  Houston, TX - 1/1/2007
• The Development of a Mid-gut Carcinoid Cell Line: “The Biology of Neuroendocrine Tumors” 
  The Banbury Center, Coldspring Harbor Laboratory, NY - 1/1/2006
• Join now to see all